Amgen Inc. (AMGN) Stock

Amgen Inc. (AMGN) is a Healthcare stock trading at $337.44 (as of 2026-06-18), with a market capitalization of $182.54B and a trailing P/E of 24.7. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics for conditions including inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience. Its product portfolio includes therapies such as Enbrel, Neulasta, Prolia, Xgeva, Otezla, and Repatha, which are marketed to healthcare providers including physicians, dialysis centers, hospitals, and pharmacies.

Valuation — source: SEC EDGAR (first-party)
Price$337.44
Market Cap$182.54B
P/E Ratio24.7
EV / EBITDA15.3
Price / Book20.86
Price / Sales5.15
Dividend Yield2.7%
DCF Value (model)$124.33
DCF Upside vs Price-63.2%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$36.75B
Net Margin21.0%
Return on Equity84.9%
Debt / Equity6.24
Current Ratio1.26
Revenue Growth (YoY)5.8%
EPS Growth (YoY)4.7%
FCF Growth (YoY)50.7%
Financial Health — source: SEC EDGAR
Altman Z-Score1.73 (distress)
Piotroski F-Score7/9 (strong)
Valuation vs Sector & Industry
Stock P/E24.7
Sector P/E (Healthcare)21.0
Industry P/E (Pharmaceutical Products)17.3
vs Sector17.9%
vs Industry43.2%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Insider Sells (12mo)3
Top Institutional HolderVANGUARD GROUP INC ($17.95B)
Institutional Holders Tracked10
Congressional Trades (recent)10
Company
SectorHealthcare
IndustryPharmaceutical Products
CEORobert A. Bradway
Employees28,000
CountryUS
IPO Date1983-06-17

Related Companies (Business model: Big Pharma / Branded Drugs; 8 closest by market cap; US-domiciled)

  • Johnson & Johnson (JNJ)
  • AbbVie Inc. (ABBV)
  • Merck & Co., Inc. (MRK)
  • Abbott Laboratories (ABT)
  • Gilead Sciences, Inc. (GILD)
  • Pfizer Inc. (PFE)
  • Bristol-Myers Squibb Company (BMY)
  • Regeneron Pharmaceuticals, Inc. (REGN)
AMGN earnings history · AMGN institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.